Patrick J. Morris

Also affiliated with National Center for Advancing Translational Sciences

MedicineNeuroscienceMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration”.

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration

Translational Psychiatry(2022)10.1038/s41398-022-01941-x

N/A

0.928DataRank · unranked

32 citations

Panos Zanos, Cristan Farmer, Bashkim Kadriu, Patrick J. Morris, Jacqueline Lovett +10 more

A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801

Neurotoxicology and Teratology(2021)10.1016/j.ntt.2021.106993

N/A

0.505DataRank · unranked

28 citations

Richard Burke, Alok Sharma, Daniel C. Lynch, Leslie E. Lemke-Boutcher, Shiny Mathew +8 more

Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2,6)- and (5R)-Methyl-(2R,6R)-hydroxynorketamines

ACS Chemical Neuroscience(2022)10.1021/acschemneuro.1c00761

N/A

0.494DataRank · unranked

26 citations

Patrick J. Morris, Kylie M. Konrath, Lace M. Riggs, Natalie R. Hagen, Panos Zanos +6 more

18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.113047

N/A

0.373DataRank · unranked

11 citations

Patrick J. Morris, Jordi Bonaventura, Hong Fan, William B. Mathews, Daniel P. Holt +7 more

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00412

N/A

0.165DataRank · unranked

2 citations

Xiaohu Zhang, Patricia Alfonso, Patrick J. Morris, Carleen Klumpp‐Thomas, Christopher Melani +12 more

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo

Microorganisms(2021)10.3390/microorganisms9030566

N/A

0DataRank · unranked

21 citations

Julie Dyall, Shuang Xu, Elizabeth A. Nelson, Elena Postnikova, Janie Liang +20 more

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs Against Ebola Virus In Vivo

Preprints.org(2021)10.20944/preprints202102.0293.v1

N/A

0DataRank · unranked

1 citations

Julie Dyall, Shuang Xu, Elizabeth A. Nelson, Elena Postnikova, Janie Liang +20 more

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Molecular Psychiatry(2021)10.1038/s41380-021-01093-2

N/A

0DataRank · unranked

266 citations

Sherry Lam, Meghan L. Carlton, Matthew A. Boehm, Juan L. Gomez, Óscar Solís +9 more

Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search

Molecular Psychiatry(2022)10.1038/s41380-022-01673-w

N/A

0DataRank · unranked

45 citations

Juan L. Gomez, Meghan L. Carlton, Sherry Lam, Marta Sánchez‐Soto, Patrick J. Morris +9 more

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2020)10.17615/wfvq-kk18

N/A

0DataRank · unranked

0 citations

Peixiong Yuan, Yuhong Fang, Cheryl L. Mayo, Xi‐Ping Huang, Todd D. Gould +15 more

Time will tell. Reply to “Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.” by Chen et al.

Molecular Psychiatry(2022)10.1038/s41380-022-01480-3

N/A

0DataRank · unranked

6 citations

Sherry Lam, Meghan L. Carlton, Matthew A. Boehm, Juan L. Gomez, Óscar Solís +9 more

Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma

Pharmaceuticals(2023)10.3390/ph16121635

N/A

0DataRank · unranked

11 citations

Patrick J. Morris, Craig J. Thomas, Michele Ceribelli, Lale Evsen

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3391

N/A

0DataRank · unranked

34 citations

Jeffrey T. Guptill, Michelle Mack, Marni Peterson, Stephen J. Byard, Robert J. Twieg +36 more

Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications

Pharmacological Reviews(2021)10.1124/pharmrev.120.000149

N/A

0DataRank · unranked

94 citations

Panos Zanos, Lace M. Riggs, Polymnia Georgiou, Sarah M. Clark, Patrick J. Morris +6 more

Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c01027

N/A

0DataRank · unranked

0 citations

Damien Duveau, Michele Ceribelli, Frances Anne Tosto, Dara N. Love, Bridget S. Scherer +9 more